We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · September 24, 2020

Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
J. Clin. Oncol 2020 Sep 18;[EPub Ahead of Print], A Gallamini, A Rossi, C Patti, M Picardi, A Romano, M Cantonetti, S Oppi, S Viviani, S Bolis, L Trentin, G Gini, R Battistini, S Chauvie, R Sorasio, C Pavoni, R Zanotti, M Cimminiello, C Schiavotto, P Viero, A Mulé, F Fallanca, U Ficola, C Tarella, L Guerra, A Rambaldi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading